APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Surfactant

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pulmonary Surfactant Market Outlook and Growth Opportunities 2026

23 December 2025193 pages

Choose your research edition.

Industry ResearchPulmonary Surfactant Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Surfactant Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Pulmonary Surfactant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Surfactant Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Surfactant Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pulmonary Surfactant market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pulmonary Surfactant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pulmonary Surfactant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pulmonary Surfactant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pulmonary Surfactant market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pulmonary Surfactant market include Abbott, Nanjing Norris Pharm Technology, AbbVie, XpressBio, Windtree Therapeutics, Tekzima (Noargen), Reddot Biotech, ONY Biotech and Lyomark Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pulmonary Surfactant market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pulmonary Surfactant and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pulmonary Surfactant sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pulmonary Surfactant market size, projected growth trends, production technologies, key applications, and end-use industries.

Pulmonary Surfactant Segment by Company

Abbott

Nanjing Norris Pharm Technology

AbbVie

XpressBio

Windtree Therapeutics

Tekzima (Noargen)

Reddot Biotech

ONY Biotech

Lyomark Pharma

LSBio

Creative Diagnostics

Boehringer Ingelheim

Biorbyt

Biomatik

Aviva Systems Biology

Pulmonary Surfactant Segment by Type

Synthetic Pulmonary Surfactants

Animal Derived Surfactants

Pulmonary Surfactant Segment by Application

Hospital

laboratory

Others

Pulmonary Surfactant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pulmonary Surfactant status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pulmonary Surfactant market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pulmonary Surfactant significant trends, drivers, influence factors in global and regions.

6. To analyze Pulmonary Surfactant competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Surfactant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Surfactant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Surfactant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pulmonary Surfactant market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pulmonary Surfactant industry.

Chapter 3: Detailed analysis of Pulmonary Surfactant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pulmonary Surfactant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pulmonary Surfactant in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pulmonary Surfactant Industry Trends Table 2. Pulmonary Surfactant Industry Drivers Table 3. Pulmonary Surfactant Industry Opportunities and Challenges Table 4. Pulmonary Surfactant Industry Restraints Table 5. Global Pulmonary Surfactant Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pulmonary Surfactant Revenue Share by Company (2021-2026) Table 7. Global Pulmonary Surfactant Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pulmonary Surfactant Sales Volume Share by Company (2021-2026) Table 9. Global Pulmonary Surfactant Average Price (US$/unit) of Company (2021-2026) Table 10. Global Pulmonary Surfactant Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pulmonary Surfactant Key Company Manufacturing Base & Headquarters Table 12. Global Pulmonary Surfactant Company, Product Type & Application Table 13. Global Pulmonary Surfactant Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pulmonary Surfactant by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Synthetic Pulmonary Surfactants Table 18. Significant Companies of Animal Derived Surfactants Table 19. Global Pulmonary Surfactant Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Pulmonary Surfactant Sales Volume by Type (2021-2026) & (k units) Table 21. Global Pulmonary Surfactant Sales Volume by Type (2027-2032) & (k units) Table 22. Global Pulmonary Surfactant Sales Volume Share by Type (2021-2026) Table 23. Global Pulmonary Surfactant Sales Volume Share by Type (2027-2032) Table 24. Global Pulmonary Surfactant Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pulmonary Surfactant Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pulmonary Surfactant Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pulmonary Surfactant Sales Value Share by Type (2021-2026) Table 28. Global Pulmonary Surfactant Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of laboratory Table 31. Significant Companies of Others Table 32. Global Pulmonary Surfactant Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Pulmonary Surfactant Sales Volume by Application (2021-2026) & (k units) Table 34. Global Pulmonary Surfactant Sales Volume by Application (2027-2032) & (k units) Table 35. Global Pulmonary Surfactant Sales Volume Share by Application (2021-2026) Table 36. Global Pulmonary Surfactant Sales Volume Share by Application (2027-2032) Table 37. Global Pulmonary Surfactant Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pulmonary Surfactant Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Pulmonary Surfactant Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Pulmonary Surfactant Sales Value Share by Application (2021-2026) Table 41. Global Pulmonary Surfactant Sales Value Share by Application (2027-2032) Table 42. Global Pulmonary Surfactant Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Pulmonary Surfactant Sales by Region (2021-2026) & (k units) Table 44. Global Pulmonary Surfactant Sales Market Share by Region (2021-2026) Table 45. Global Pulmonary Surfactant Sales by Region (2027-2032) & (k units) Table 46. Global Pulmonary Surfactant Sales Market Share by Region (2027-2032) Table 47. Global Pulmonary Surfactant Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Pulmonary Surfactant Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Pulmonary Surfactant Sales Value Share by Region (2021-2026) Table 50. Global Pulmonary Surfactant Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Pulmonary Surfactant Sales Value Share by Region (2027-2032) Table 52. Global Pulmonary Surfactant Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Pulmonary Surfactant Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Pulmonary Surfactant Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Pulmonary Surfactant Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 57. Global Pulmonary Surfactant Sales Market Share by Country (2021-2026) Table 58. Global Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 59. Global Pulmonary Surfactant Sales Market Share by Country (2027-2032) Table 60. Global Pulmonary Surfactant Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Pulmonary Surfactant Sales Value Market Share by Country (2021-2026) Table 62. Global Pulmonary Surfactant Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Pulmonary Surfactant Sales Value Market Share by Country (2027-2032) Table 64. Abbott Company Information Table 65. Abbott Business Overview Table 66. Abbott Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Abbott Pulmonary Surfactant Product Portfolio Table 68. Abbott Recent Development Table 69. Nanjing Norris Pharm Technology Company Information Table 70. Nanjing Norris Pharm Technology Business Overview Table 71. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio Table 73. Nanjing Norris Pharm Technology Recent Development Table 74. AbbVie Company Information Table 75. AbbVie Business Overview Table 76. AbbVie Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. AbbVie Pulmonary Surfactant Product Portfolio Table 78. AbbVie Recent Development Table 79. XpressBio Company Information Table 80. XpressBio Business Overview Table 81. XpressBio Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. XpressBio Pulmonary Surfactant Product Portfolio Table 83. XpressBio Recent Development Table 84. Windtree Therapeutics Company Information Table 85. Windtree Therapeutics Business Overview Table 86. Windtree Therapeutics Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Windtree Therapeutics Pulmonary Surfactant Product Portfolio Table 88. Windtree Therapeutics Recent Development Table 89. Tekzima (Noargen) Company Information Table 90. Tekzima (Noargen) Business Overview Table 91. Tekzima (Noargen) Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Tekzima (Noargen) Pulmonary Surfactant Product Portfolio Table 93. Tekzima (Noargen) Recent Development Table 94. Reddot Biotech Company Information Table 95. Reddot Biotech Business Overview Table 96. Reddot Biotech Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Reddot Biotech Pulmonary Surfactant Product Portfolio Table 98. Reddot Biotech Recent Development Table 99. ONY Biotech Company Information Table 100. ONY Biotech Business Overview Table 101. ONY Biotech Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. ONY Biotech Pulmonary Surfactant Product Portfolio Table 103. ONY Biotech Recent Development Table 104. Lyomark Pharma Company Information Table 105. Lyomark Pharma Business Overview Table 106. Lyomark Pharma Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Lyomark Pharma Pulmonary Surfactant Product Portfolio Table 108. Lyomark Pharma Recent Development Table 109. LSBio Company Information Table 110. LSBio Business Overview Table 111. LSBio Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. LSBio Pulmonary Surfactant Product Portfolio Table 113. LSBio Recent Development Table 114. Creative Diagnostics Company Information Table 115. Creative Diagnostics Business Overview Table 116. Creative Diagnostics Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Creative Diagnostics Pulmonary Surfactant Product Portfolio Table 118. Creative Diagnostics Recent Development Table 119. Boehringer Ingelheim Company Information Table 120. Boehringer Ingelheim Business Overview Table 121. Boehringer Ingelheim Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Boehringer Ingelheim Pulmonary Surfactant Product Portfolio Table 123. Boehringer Ingelheim Recent Development Table 124. Biorbyt Company Information Table 125. Biorbyt Business Overview Table 126. Biorbyt Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Biorbyt Pulmonary Surfactant Product Portfolio Table 128. Biorbyt Recent Development Table 129. Biomatik Company Information Table 130. Biomatik Business Overview Table 131. Biomatik Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Biomatik Pulmonary Surfactant Product Portfolio Table 133. Biomatik Recent Development Table 134. Aviva Systems Biology Company Information Table 135. Aviva Systems Biology Business Overview Table 136. Aviva Systems Biology Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Aviva Systems Biology Pulmonary Surfactant Product Portfolio Table 138. Aviva Systems Biology Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Pulmonary Surfactant Distributors List Table 142. Pulmonary Surfactant Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Pulmonary Surfactant Product Image Figure 2. Global Pulmonary Surfactant Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Surfactant Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pulmonary Surfactant Sales (2021-2032) & (k units) Figure 5. Global Pulmonary Surfactant Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Pulmonary Surfactant Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Synthetic Pulmonary Surfactants Image Figure 10. Animal Derived Surfactants Image Figure 11. Global Pulmonary Surfactant Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Pulmonary Surfactant Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pulmonary Surfactant Sales Volume Share by Type (2021-2032) Figure 14. Global Pulmonary Surfactant Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pulmonary Surfactant Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pulmonary Surfactant Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. laboratory Image Figure 19. Others Image Figure 20. Global Pulmonary Surfactant Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Pulmonary Surfactant Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Pulmonary Surfactant Sales Volume Share by Application (2021-2032) Figure 23. Global Pulmonary Surfactant Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pulmonary Surfactant Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Pulmonary Surfactant Sales Value Share by Application (2021-2032) Figure 26. Global Pulmonary Surfactant Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Pulmonary Surfactant Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Pulmonary Surfactant Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Pulmonary Surfactant Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Pulmonary Surfactant Sales Value (2021-2032) & (US$ Million) Figure 31. North America Pulmonary Surfactant Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Pulmonary Surfactant Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Pulmonary Surfactant Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Pulmonary Surfactant Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Pulmonary Surfactant Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Pulmonary Surfactant Sales Value (2021-2032) & (US$ Million) Figure 37. South America Pulmonary Surfactant Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Pulmonary Surfactant Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Pulmonary Surfactant Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Pulmonary Surfactant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Pulmonary Surfactant Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Pulmonary Surfactant Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Synthetic Pulmonary Surfactants
  • Animal Derived Surfactants
Applications
  • Hospital
  • laboratory
  • Others
Companies covered
  • Abbott
  • Nanjing Norris Pharm Technology
  • AbbVie
  • XpressBio
  • Windtree Therapeutics
  • Tekzima (Noargen)
  • Reddot Biotech
  • ONY Biotech
  • Lyomark Pharma
  • LSBio
  • Creative Diagnostics
  • Boehringer Ingelheim
  • Biorbyt
  • Biomatik
  • Aviva Systems Biology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pulmonary Surfactant Sales Value (2021-2032)
  4. 1.2.2 Global Pulmonary Surfactant Sales Volume (2021-2032)
  5. 1.2.3 Global Pulmonary Surfactant Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pulmonary Surfactant Market Dynamics
  1. 2.1 Pulmonary Surfactant Industry Trends
  2. 2.2 Pulmonary Surfactant Industry Drivers
  3. 2.3 Pulmonary Surfactant Industry Opportunities and Challenges
  4. 2.4 Pulmonary Surfactant Industry Restraints
3 Pulmonary Surfactant Market by Company
  1. 3.1 Global Pulmonary Surfactant Company Revenue Ranking in 2025
  2. 3.2 Global Pulmonary Surfactant Revenue by Company (2021-2026)
  3. 3.3 Global Pulmonary Surfactant Sales Volume by Company (2021-2026)
  4. 3.4 Global Pulmonary Surfactant Average Price by Company (2021-2026)
  5. 3.5 Global Pulmonary Surfactant Company Ranking (2024-2026)
  6. 3.6 Global Pulmonary Surfactant Company Manufacturing Base and Headquarters
  7. 3.7 Global Pulmonary Surfactant Company Product Type and Application
  8. 3.8 Global Pulmonary Surfactant Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pulmonary Surfactant Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pulmonary Surfactant Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pulmonary Surfactant Market by Type
  1. 4.1 Pulmonary Surfactant Type Introduction
  2. 4.1.1 Synthetic Pulmonary Surfactants
  3. 4.1.2 Animal Derived Surfactants
  4. 4.2 Global Pulmonary Surfactant Sales Volume by Type
  5. 4.2.1 Global Pulmonary Surfactant Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pulmonary Surfactant Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pulmonary Surfactant Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pulmonary Surfactant Sales Value by Type
  9. 4.3.1 Global Pulmonary Surfactant Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pulmonary Surfactant Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pulmonary Surfactant Sales Value Share by Type (2021-2032)
5 Pulmonary Surfactant Market by Application
  1. 5.1 Pulmonary Surfactant Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 laboratory
  4. 5.1.3 Others
  5. 5.2 Global Pulmonary Surfactant Sales Volume by Application
  6. 5.2.1 Global Pulmonary Surfactant Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pulmonary Surfactant Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pulmonary Surfactant Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pulmonary Surfactant Sales Value by Application
  10. 5.3.1 Global Pulmonary Surfactant Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pulmonary Surfactant Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pulmonary Surfactant Sales Value Share by Application (2021-2032)
6 Pulmonary Surfactant Regional Sales and Value Analysis
  1. 6.1 Global Pulmonary Surfactant Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pulmonary Surfactant Sales by Region (2021-2032)
  3. 6.2.1 Global Pulmonary Surfactant Sales by Region: 2021-2026
  4. 6.2.2 Global Pulmonary Surfactant Sales by Region (2027-2032)
  5. 6.3 Global Pulmonary Surfactant Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pulmonary Surfactant Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pulmonary Surfactant Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pulmonary Surfactant Sales Value by Region (2027-2032)
  9. 6.5 Global Pulmonary Surfactant Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pulmonary Surfactant Sales Value (2021-2032)
  12. 6.6.2 North America Pulmonary Surfactant Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pulmonary Surfactant Sales Value (2021-2032)
  15. 6.7.2 Europe Pulmonary Surfactant Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pulmonary Surfactant Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pulmonary Surfactant Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pulmonary Surfactant Sales Value (2021-2032)
  21. 6.9.2 South America Pulmonary Surfactant Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pulmonary Surfactant Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pulmonary Surfactant Sales Value Share by Country, 2025 VS 2032
7 Pulmonary Surfactant Country-level Sales and Value Analysis
  1. 7.1 Global Pulmonary Surfactant Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pulmonary Surfactant Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pulmonary Surfactant Sales by Country (2021-2032)
  4. 7.3.1 Global Pulmonary Surfactant Sales by Country (2021-2026)
  5. 7.3.2 Global Pulmonary Surfactant Sales by Country (2027-2032)
  6. 7.4 Global Pulmonary Surfactant Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pulmonary Surfactant Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pulmonary Surfactant Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pulmonary Surfactant Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pulmonary Surfactant Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pulmonary Surfactant Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Pulmonary Surfactant Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Nanjing Norris Pharm Technology
  8. 8.2.1 Nanjing Norris Pharm Technology Company Information
  9. 8.2.2 Nanjing Norris Pharm Technology Business Overview
  10. 8.2.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio
  12. 8.2.5 Nanjing Norris Pharm Technology Recent Developments
  13. 8.3 AbbVie
  14. 8.3.1 AbbVie Company Information
  15. 8.3.2 AbbVie Business Overview
  16. 8.3.3 AbbVie Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 AbbVie Pulmonary Surfactant Product Portfolio
  18. 8.3.5 AbbVie Recent Developments
  19. 8.4 XpressBio
  20. 8.4.1 XpressBio Company Information
  21. 8.4.2 XpressBio Business Overview
  22. 8.4.3 XpressBio Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 XpressBio Pulmonary Surfactant Product Portfolio
  24. 8.4.5 XpressBio Recent Developments
  25. 8.5 Windtree Therapeutics
  26. 8.5.1 Windtree Therapeutics Company Information
  27. 8.5.2 Windtree Therapeutics Business Overview
  28. 8.5.3 Windtree Therapeutics Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Windtree Therapeutics Pulmonary Surfactant Product Portfolio
  30. 8.5.5 Windtree Therapeutics Recent Developments
  31. 8.6 Tekzima (Noargen)
  32. 8.6.1 Tekzima (Noargen) Company Information
  33. 8.6.2 Tekzima (Noargen) Business Overview
  34. 8.6.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tekzima (Noargen) Pulmonary Surfactant Product Portfolio
  36. 8.6.5 Tekzima (Noargen) Recent Developments
  37. 8.7 Reddot Biotech
  38. 8.7.1 Reddot Biotech Company Information
  39. 8.7.2 Reddot Biotech Business Overview
  40. 8.7.3 Reddot Biotech Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Reddot Biotech Pulmonary Surfactant Product Portfolio
  42. 8.7.5 Reddot Biotech Recent Developments
  43. 8.8 ONY Biotech
  44. 8.8.1 ONY Biotech Company Information
  45. 8.8.2 ONY Biotech Business Overview
  46. 8.8.3 ONY Biotech Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 ONY Biotech Pulmonary Surfactant Product Portfolio
  48. 8.8.5 ONY Biotech Recent Developments
  49. 8.9 Lyomark Pharma
  50. 8.9.1 Lyomark Pharma Company Information
  51. 8.9.2 Lyomark Pharma Business Overview
  52. 8.9.3 Lyomark Pharma Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lyomark Pharma Pulmonary Surfactant Product Portfolio
  54. 8.9.5 Lyomark Pharma Recent Developments
  55. 8.10 LSBio
  56. 8.10.1 LSBio Company Information
  57. 8.10.2 LSBio Business Overview
  58. 8.10.3 LSBio Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 LSBio Pulmonary Surfactant Product Portfolio
  60. 8.10.5 LSBio Recent Developments
  61. 8.11 Creative Diagnostics
  62. 8.11.1 Creative Diagnostics Company Information
  63. 8.11.2 Creative Diagnostics Business Overview
  64. 8.11.3 Creative Diagnostics Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Creative Diagnostics Pulmonary Surfactant Product Portfolio
  66. 8.11.5 Creative Diagnostics Recent Developments
  67. 8.12 Boehringer Ingelheim
  68. 8.12.1 Boehringer Ingelheim Company Information
  69. 8.12.2 Boehringer Ingelheim Business Overview
  70. 8.12.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Boehringer Ingelheim Pulmonary Surfactant Product Portfolio
  72. 8.12.5 Boehringer Ingelheim Recent Developments
  73. 8.13 Biorbyt
  74. 8.13.1 Biorbyt Company Information
  75. 8.13.2 Biorbyt Business Overview
  76. 8.13.3 Biorbyt Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Biorbyt Pulmonary Surfactant Product Portfolio
  78. 8.13.5 Biorbyt Recent Developments
  79. 8.14 Biomatik
  80. 8.14.1 Biomatik Company Information
  81. 8.14.2 Biomatik Business Overview
  82. 8.14.3 Biomatik Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Biomatik Pulmonary Surfactant Product Portfolio
  84. 8.14.5 Biomatik Recent Developments
  85. 8.15 Aviva Systems Biology
  86. 8.15.1 Aviva Systems Biology Company Information
  87. 8.15.2 Aviva Systems Biology Business Overview
  88. 8.15.3 Aviva Systems Biology Pulmonary Surfactant Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Aviva Systems Biology Pulmonary Surfactant Product Portfolio
  90. 8.15.5 Aviva Systems Biology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pulmonary Surfactant Value Chain Analysis
  2. 9.1.1 Pulmonary Surfactant Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pulmonary Surfactant Sales Mode & Process
  6. 9.2 Pulmonary Surfactant Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pulmonary Surfactant Distributors
  9. 9.2.3 Pulmonary Surfactant Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst